piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells
Promising progress has been made in adoptive transfer of allogeneic natural killer (NK) cells to treat relapsed or refractory acute myeloid leukemia (AML). In this regard, chimeric antigen receptor (CAR)-modification of NK cells is considered as a compelling approach to augment the specificity and c...
Guardado en:
Autores principales: | Zhicheng Du, Yu Yang Ng, Shijun Zha, Shu Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3132fa6da25c405aa493feb06a356658 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Phenotypic Screens Identify Parasite Genetic Factors Associated with Malarial Fever Response in <named-content content-type="genus-species">Plasmodium falciparum</named-content><italic toggle="yes">piggyBac</italic> Mutants
por: Phaedra Thomas, et al.
Publicado: (2016) -
piggyPrime: High-Efficacy Prime Editing in Human Cells Using piggyBac-Based DNA Transposition
por: Jonas Holst Wolff, et al.
Publicado: (2021) -
POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE
por: E. A. Shulenina, et al.
Publicado: (2017) -
INHIBITION OF THE NKG2D ACTIVATING RECEPTOR EXPRESSION ON CYTOTOXIC LYMPHOCYTES BY RECOMBINANT MICA PROTEIN
por: E. V. Abakushina, et al.
Publicado: (2017) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Sergey Kulemzin, et al.
Publicado: (2021)